Metal-based nanoparticles for the treatment of infectious diseases

Molecules

Volumn 22, Issue 8, 2017, Pages

  Aderibigbe, Blessing Atim ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Cervical cancer; Herpes; HIV; Infectious diseases; Influenza; Malaria; Metal based therapeutics; Tuberculosis

Indexed keywords

METAL NANOPARTICLE;

BACTERIUM; COMMUNICABLE DISEASE; DRUG EFFECTS; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; PARASITOLOGY; PATHOGENICITY; VIROLOGY; VIRUS;

BACTERIA; COMMUNICABLE DISEASES; DRUG RESISTANCE, MULTIPLE; HUMANS; METAL NANOPARTICLES; VIRUSES;

EID: 85028022150     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22081370     Document Type: Review

References (240)

1. Morens, D.M.; Fauci, A.S. Emerging infectious diseases: Threats to human health and global stability. PLoS Pathog. 2013, 9, e1003467. [CrossRef] [PubMed]
2. Fauci, A.S.; Morens, D.M. The perpetual challenge of infectious diseases. N. Eng. J. Med. 2012, 366, 454-461. [CrossRef] [PubMed]
3. Parrish, C.R.; Holmes, E.C.; Morens, D.M.; Park, E.C.; Burke, D.S.; Calisher, C.H.; Laughlin, C.A.; Saif, L.J.; Daszak, P. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 2008, 72, 457-470. [CrossRef] [PubMed]
4. National Institutes of Health (US). Biological sciences curriculum study NIH curriculum supplement series. In Understanding Emerging and Re-emerging Infectious Diseases; National Institutes of Health (US): Bethesda, MD, USA, 2007. Available online: https://www.ncbi.nlm.nih.gov/books/NBK20370/(accessed on 20 April 2017).
5. Casadevall, A. Antibody-based therapies for emerging infectious diseases. Emerg. Infect. Dis. 1996, 2, 200. [CrossRef] [PubMed]
6. Saylor, C.; Dadachova, E.; Casadevall, A. Monoclonal antibody-based therapies for microbial diseases. Vaccine 2009, 27, G38-G46. [CrossRef] [PubMed]
7. Mody, V.V.; Siwale, R.; Singh, A.; Mody, H.R. Introduction to metallic nanoparticles. J. Pharm. Bioall. Sci. 2010, 2, 282-289. [CrossRef] [PubMed]
8. Ribet, D.; Cossart, P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 2015, 17, 173-183. [CrossRef] [PubMed]
9. Melville, S.; Craig, L. Type IV pili in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2013, 77, 323-341. [CrossRef] [PubMed]
10. Pizarro-Cerda, J.; Cossart, P. Bacterial adhesion and entry into host cells. Cell 2006, 124, 715-727. [CrossRef] [PubMed]
11. Chamot-Rooke, J.; Mikaty, G.; Malosse, C.; Soyer, M.; Dumont, A.; Gault, J.; Imhaus, A.F.; Martin, P.; Trellet, M.; Clary, G.; et al. Posttranslational modification of pili upon cell contact triggers N. meningitis dissemination. Science 2011, 331, 778-782. [CrossRef] [PubMed]
12. Hall-Stoodley, L.; Costerton, J.W.; Stoodley, P. Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2, 95-108. [CrossRef] [PubMed]
13. Joo, H.S.; Otto, M. Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem. Biol. 2012, 19, 1503-1513. [CrossRef] [PubMed]
14. McManus, M.C. Mechanisms of bacterial resistance to antimicrobial agents. Am. J. Health Syst. Pharm. 1997, 54, 1420-1433. [PubMed]
15. Munita, J.M.; Arias, C.A. Mechanisms of antibiotic resistance. Microbiol. Spectr. 2016, 4. [CrossRef]
16. Courvalin, P. Antimicrobial drug resistance: "Prediction is very difficult, especially about the future". Emerg. Infect. Dis. 2005, 11, 1503-1506. [CrossRef] [PubMed]
17. Kumar, S.; Varela, M.F. Molecular mechanisms of bacterial resistance to antimicrobial agents. In Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education;Méndez-Vilas, A., Ed.; Formatex Research Centre: Malaga, Spain, 2013; Volume 1, pp. 522-534.
18. Roberts, M.C. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 2005, 245, 195-203. [CrossRef] [PubMed]
19. Roberts, M.C. Tetracycline therapy: Update. Clin. Infect. Dis. 2003, 36, 462-467. [CrossRef] [PubMed]
20. Ammons, M.C. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat. Anti Infect. Drug Dis. 2010, 5, 10-17. [CrossRef]
21. Arvizo, R.R.; Bhattacharyya, S.; Kudgus, R.A.; Giri, K.; Bhattacharya, R.; Mukherjee, P. Intrinsic therapeutic applications of noble metal nanoparticles: Past, present and future. Chem. Soc. Rev. 2012, 41, 2943-2970. [CrossRef] [PubMed]
22. Zain, N.M.; Stapley, A.G.; Shama, G. Green synthesis of silver and copper nanoparticles using ascorbic acid and chitosan for antimicrobial applications. Carbohydr. Polym. 2014, 112, 195-202. [CrossRef] [PubMed]
23. Singh, M.; Manikandan, S.; Kumaraguru, A.K. Nanoparticles: A new technology with wide applications. Res. J. Nanosci. Nanotechnol. 2011, 1, 1-11. [CrossRef]
24. Choi, O.; Deng, K.K.; Kim, N.J.; Ross, L.; Surampalli, R.Y.; Hu, Z.Q. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008, 42, 3066-3074. [CrossRef] [PubMed]
25. Feng, Q.L.; Wu, J.; Chen, G.Q.; Cui, F.Z.; Kim, T.N.; Kim, J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 2000, 52, 662-668. [CrossRef]
26. Sondi, I.; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 2004, 275, 177-182. [CrossRef] [PubMed]
27. Prabhu, S.; Poulose, E.K. Silver nanoparticles: Mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int. Nano Lett. 2012, 2, 32. [CrossRef]
28. Kim, J.S.; Kuk, E.; Yu, K.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.-Y.; et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3, 95-101. [CrossRef] [PubMed]
29. Lu, Z.; Rong, K.; Li, J.; Yang, H.; Chen, R. Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J. Mater. Sci. Mater. Med. 2013, 24, 1465-1471. [CrossRef] [PubMed]
30. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramirez, J.T.; Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnol 2005, 16, 2346-2353. [CrossRef] [PubMed]
31. Raza, M.A.; Kanwal, Z.; Rauf, A.; Sabri, A.N.; Riaz, S.; Naseem, S. Size-and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomater 2016, 6. [CrossRef] [PubMed]
32. Pal, S.; Tak, Y.K.; Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73, 1712-1720. [CrossRef] [PubMed]
33. Van Dong, P.; Ha, C.H.; Kasbohm, J. Chemical synthesis and antibacterial activity of novel-shaped silver nanoparticles. Int. Nano Lett. 2012, 2, 9. [CrossRef]
34. Rai, M.; Yadav, A.; Gade, A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 2009, 27, 76-83. [CrossRef] [PubMed]
35. Sadeghi, B.; Garmaroudi, F.S.; Hashemi, M.; Nezhad, H.R.; Nasrollahi, A.; Ardalan, S.; Ardalan, S. Comparison of the anti-bacterial activity on the nanosilver shapes: Nanoparticles, nanorods and nanoplates. Adv. Powder Technol. 2012, 23, 22-26. [CrossRef]
36. Romaniuk, J.A.; Cegelski, L. Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR. Philos. Trans. R. Soc. B 2015, 370. [CrossRef] [PubMed]
37. Hong, X.;Wen, J.; Xiong, X.; Hu, Y. Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method. Environ. Sci. Pollut. Res. 2016, 23, 4489-4497. [CrossRef] [PubMed]
38. Jafari, A.R.; Mosavi, T.; Mosavari, N.; Majid, A.; Movahedzade, F.; Tebyaniyan, M.; Arastoo, S. Mixed metal oxide nanoparticles inhibit growth of Mycobacterium tuberculosis into THP-1 cells. Int. J. Mycobacteriol. 2016, 5, S181-S183. [CrossRef] [PubMed]
39. Praba, V.L.; Kathirvel, M.; Vallayyachari, K.; Surendar, K.; Muthuraj, M.; Jesuraj, P.J.; Govindarajan, S.; Raman, K.V. Bactericidal effect of silver nanoparticles against Mycobacterium tuberculosis. J. Bionanosci. 2013, 3, 282-287. [CrossRef]
40. Singh, R.; Nawale, L.U.; Arkile, M.; Shedbalkar, U.U.; Wadhwani, S.A.; Sarkar, D.; Chopade, B.A. Chemical and biological metal nanoparticles as antimycobacterial agents: A comparative study. Int. J. Antimicrob. Agents. 2015, 46, 183-188. [CrossRef] [PubMed]
41. Yilma, A.N.; Singh, S.R.; Dixit, S.; Dennis, V.A. Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis. Int. J. Nanomed. 2013, 8, 2421-2432.
42. Alexander, J.W. History of the medical use of a silver. Surg. Infect. 2009, 10, 289-292. [CrossRef] [PubMed]
43. Jacob Inbaneson, S.; Ravikumar, S.; Manikandan, N. Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens. Appl. Nanosci. 2011, 1, 231-236. [CrossRef]
44. Pickard, R.; Lam, T.; MacLennan, G.; Starr, K.; Kilonzo, M.; McPherson, G.; Gillies, K.; McDonald, A.; Walton, K.; Buckley, B.; et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: A multicentre randomised controlled trial. Lancet 2012, 380, 1927-1935. [CrossRef]
45. Ritter, J.; Thomas, L.; Lederer, J.; Jarvis, W.R. Effectiveness of a silver-alloy and hydrogel coated urinary catheter on symptomatic catheter-associated urinary tract infections. Am. J. Infect. Control. 2013, 41, S143-S144. [CrossRef]
46. Ford, J.; Hughes, G.; Phillips, P. Literature Review of Silver-Coated Urinary Catheters-Draft SMTL January 2014. Available online: http://www.medidex.com/research/830-silver-coated-catheters-full-article.html (accessed on 7 July 2017).
47. Thibon, P.; Le Coutour, X.; Leroyer, R.; Fabry, J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J. Hosp. Infect. 2000, 45, 117-124. [CrossRef] [PubMed]
48. Srinivasan, A.; Karchmer, T.; Richards, A.; Song, X.; Perl, T.M. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect. Control Hosp. Epidemiol. 2006, 27, 38-43. [CrossRef] [PubMed]
49. Wan, G.; Ruan, L.; Yin, Y.; Yang, T.; Ge, M.; Cheng, X. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii. Int. J. Nanomed. 2016, 11, 3789-3800. [CrossRef] [PubMed]
50. Li, P.; Li, J.; Wu, C.; Wu, Q.; Li, J. Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnol 2005, 16, 1912-1917. [CrossRef]
51. Deng, H.; McShan, D.; Zhang, Y.; Sinha, S.S.; Arslan, Z.; Ray, P.C.; Yu, H. Mechanistic study of the synergistic antibacterial activity of combined silver nanoparticles and common antibiotics. Environ. Sci. Technol. 2016, 50, 8840-8848. [CrossRef] [PubMed]
52. Smekalova, M.; Aragon, V.; Panacek, A.; Prucek, R.; Zboril, R.; Kvitek, L. Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens. Vet. J. 2016, 209, 174-179. [CrossRef] [PubMed]
53. Akram, F.E.; El-Tayeb, T.; Abou-Aisha, K.; El-Azizi, M. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). Ann. Clin. Microb. Antimicrob. 2016, 15, 48. [CrossRef] [PubMed]
54. Thirumurugan, G.; Rao, J.S.; Dhanaraju, M.D. Elucidating pharmacodynamic interaction of silver nanoparticle-topical deliverable antibiotics. Sci. Rep. 2016, 6, 29982. [CrossRef] [PubMed]
55. Balaji Raja, R.; Singh, P. Synergistic effect of silver nanoparticles with the cephalexin antibiotic against the test strains. Biores. Bull. 2012, 2, 171-179.
56. Fatimah, I. Green synthesis of silver nanoparticles using extract of Parkia speciosa Hassk pods assisted by microwave irradiation. J. Adv. Res. 2016, 7, 961-969. [CrossRef] [PubMed]
57. Verma, A.; Mehata, M.S. Controllable synthesis of silver nanoparticles using Neem leaves and their antimicrobial activity. J. Radiat. Res. Appl. Sci. 2016, 9, 109-115. [CrossRef]
58. Tripathy, A.; Raichur, A.M.; Chandrasekaran, N.; Prathna, T.C.; Mukherjee, A. Process variables in biomimetic synthesis of silver nanoparticles by aqueous extract of Azadirachta indica (Neem) leaves. J. Nanopart. Res. 2010, 12, 237-246. [CrossRef]
59. Krishnaraj, C.; Jagan, E.G.; Rajasekar, S.; Selvakumar, P.; Kalaichelvan, P.T.; Mohan, N. Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloids Surf. B 2010, 76, 50-56. [CrossRef] [PubMed]
60. Ponarulselvam, S.; Panneerselvam, C.; Murugan, K.; Aarthi, N.; Kalimuthu, K.; Thangamani, S. Synthesis of silver nanoparticles using leaves of Catharanthus roseus Linn. G. Don and their antiplasmodial activities. Asian Pac. J. Trop. Biomed. 2012, 2, 574-580. [CrossRef]
61. Tippayawat, P.; Phromviyo, N.; Boueroy, P.; Chompoosor, A. Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity. Peer J. 2016, 4. [CrossRef] [PubMed]
62. Ali, Z.A.; Yahya, R.; Sekaran, S.D.; Puteh, R. Green synthesis of silver nanoparticles using apple extract and its antibacterial properties. Adv. Mater. Sci. Eng. 2016. [CrossRef]
63. Allafchian, A.R.; Mirahmadi-Zare, S.Z.; Jalali, S.A.; Hashemi, S.S.; Vahabi, M.R. Green synthesis of silver nanoparticles using phlomis. J. Nanostr. Chem. 2016, 6, 129-135. [CrossRef]
64. Maiti, S.; Krishnan, D.; Barman, G.; Ghosh, S.K.; Laha, J.K. Antimicrobial activities of silver nanoparticles synthesized from Lycopersicon esculentum extract. J. Anal. Sci. Technol. 2014, 5. [CrossRef]
65. Chiguvare, H.; Oyedeji, O.O.; Matewu, R.; Aremu, O.; Oyemitan, I.A.; Oyedeji, A.O.; Nkeh-Chungag, B.N.; Songca, S.P.; Mohan, S.; Oluwafemi, O.S. Synthesis of Silver Nanoparticles Using Buchu Plant Extracts and Their Analgesic Properties. Molecules 2016, 21. [CrossRef] [PubMed]
66. Singhal, G.; Bhavesh, R.; Kasariya, K.; Sharma, A.R.; Singh, R.P. Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J. Nanopart. Res. 2011, 13, 2981-2988. [CrossRef]
67. Singh, T.; Jyoti, K.; Patnaik, A.; Singh, A.; Chauhan, R.; Chandel, S.S. Biosynthesis, characterization and antibacterial activity of silver nanoparticles using an endophytic fungal supernatant of Raphanus sativus. J. Genet. Eng. Biotechnol. 2017, 15, 31-39. [CrossRef]
68. El-Sheekh, M.M.; El-Kassas, H.Y. Algal production of nano-silver and gold: Their antimicrobial and cytotoxic activities: A review. J. Genet. Eng. Biotechnol. 2016, 14, 299-310. [CrossRef]
69. Saravanan, C.; Rajesh, R.; Kaviarasan, T.; Muthukumar, K.; Kavitake, D.; Shetty, P.H. Synthesis of silver nanoparticles using bacterial exopolysaccharide and its application for degradation of azo-dyes. Biotechnol. Rep. 2017, 15, 33-40. [CrossRef] [PubMed]
70. Narayanan, K.B.; Sakthivel, N. Biological synthesis of metal nanoparticles by microbes. Adv. Colloid Interface Sci. 2010, 156, 1-13. [CrossRef] [PubMed]
71. Ashajyothi, C.; Oli, A.K.; Prabhurajeshwar, C. Potential bactericidal effect of silver nanoparticles synthesised from Enterococcus species. Orient. J. Chem. 2014, 30, 1253-1262.
72. Minaeian, S.; Shahverdi, A.R.; Nohi, A.S.; Shahverdi, H.R. Extracellular biosynthesis of silver nanoparticles by some bacteria. J. Sci. IAU 2008, 17, 1-4.
73. Shirley, A.D.; Dayanand, A.; Sreedhar, B.; Dastager, S.G. Antimicrobial activity of silver nanoparticles synthesized from novel Streptomyces species. Dig. J. Nanomater. Biostruct. 2010, 5, 447-451.
74. Prabhu, Y.T.; Rao, K.V.; Kumari, B.S.; Kumar, V.S.; Pavani, T. Synthesis of Fe3O4 nanoparticles and its antibacterial application. Int. Nano Lett. 2015, 5, 85-92. [CrossRef]
75. Mahdavi, M.; Namvar, F.; Ahmad, M.B.; Mohamad, R. Green biosynthesis and characterization of magnetic iron oxide (Fe3O4) nanoparticles using seaweed (Sargassum muticum) aqueous extract. Molecules. 2013, 18, 5954-5964. [CrossRef] [PubMed]
76. Arokiyaraj, S.; Saravanan, M.; Prakash, N.U.; Arasu, M.V.; Vijayakumar, B.; Vincent, S. Enhanced antibacterial activity of iron oxide magnetic nanoparticles treated with Argemone mexicana L. leaf extract: An in vitro study. Mater. Res. Bull. 2013, 48, 3323-3327. [CrossRef]
77. Makarov, V.V.; Makarova, S.S.; Love, A.J.; Sinitsyna, O.V.; Dudnik, A.O.; Yaminsky, I.V.; Taliansky, M.E.; Kalinina, N.O. Biosynthesis of stable iron oxide nanoparticles in aqueous extracts of Hordeum vulgare and Rumex acetosa plants. Langmuir 2014, 30, 5982-5988. [CrossRef] [PubMed]
78. Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021. [CrossRef] [PubMed]
79. Rafi, M.M.; Ahmed, K.S.; Nazeer, K.P.; Kumar, D.S.; Thamilselvan, M. Synthesis, characterization and magnetic properties of hematite (α-Fe2O3) nanoparticles on polysaccharide templates and their antibacterial activity. Appl. Nanosci. 2015, 5, 515-520. [CrossRef]
80. Behera, S.S.; Patra, J.K.; Pramanik, K.; Panda, N.; Thatoi, H. Characterization and evaluation of antibacterial activities of chemically synthesized iron oxide nanoparticles. World J. Nano Sci. Eng. 2012, 2, 196-200. [CrossRef]
81. Ismail, R.A.; Sulaiman, G.M.; Abdulrahman, S.A.; Marzoog, T.R. Antibacterial activity of magnetic iron oxide nanoparticles synthesized by laser ablation in liquid. Mater. Sci. Eng. 2015, 53, 286-297. [CrossRef] [PubMed]
82. Arakha, M.; Pal, S.; Samantarrai, D.; Panigrahi, T.K.; Mallick, B.C.; Pramanik, K.; Mallick, B.; Jha, S. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci. Rep. 2015, 5, 14813. [CrossRef] [PubMed]
83. Irshad, R.; Tahir, K.; Li, B.; Ahmad, A.; Siddiqui, A.R.; Nazir, S. Antibacterial activity of biochemically capped iron oxide nanoparticles: A view towards green chemistry. J. Photochem. Photobiol. B Biol. 2017, 170, 241-246. [CrossRef] [PubMed]
84. Aparicio-Caamaño, M.; Carrillo-Morales, M.; Olivares-Trejo, J.J. Iron Oxide Nanoparticle Improves the Antibacterial Activity of Erythromycin. J. Bacteriol. Parasitol. 2016, 7, 267. [CrossRef]
85. Tran, N.; Mir, A.; Mallik, D.; Sinha, A.; Nayar, S.;Webster, T.J. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int. J. Nanomed. 2010, 5, 277-283.
86. Inbaraj, B.S.; Tsai, T.Y.; Chen, B.H. Synthesis, characterization and antibacterial activity of superparamagnetic nanoparticles modified with glycol chitosan. Sci. Technol. Adv. Mater. 2012, 13, 015002. [CrossRef] [PubMed]
87. Masadeh, M.M.; Karasneh, G.A.; Al-Akhras, M.A.; Albiss, B.A.; Aljarah, K.M.; Al-Azzam, S.I.; Alzoubi, K.H. Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria. Cytotechnol 2015, 67, 427-435. [CrossRef] [PubMed]
88. Ahmad, T.; Phul, R.; Khatoon, N.; Sardar, M. Antibacterial efficacy of Ocimum sanctum leaf extract-treated iron oxide nanoparticles. N. J. Chem. 2017, 41, 2055-2061. [CrossRef]
89. Huang, L.; Weng, X.; Chen, Z.; Megharaj, M.; Naidu, R. Synthesis of iron-based nanoparticles using oolong tea extract for the degradation of malachite green. Spect. Acta Part A 2014, 117, 801-804. [CrossRef] [PubMed]
90. Njagi, E.C.; Huang, H.; Stafford, L.; Genuino, H.; Galindo, H.M.; Collins, J.B.; Hoag, G.E.; Suib, S.L. Biosynthesis of iron and silver nanoparticles at room temperature using aqueous sorghum bran extracts. Langmuir 2011, 27, 264-271. [CrossRef] [PubMed]
91. Madhavi, V.; Prasad, T.N.; Reddy, A.V.; Ravindra Reddy, B.; Madhavi, G. Application of phytogenic zerovalent iron nanoparticles in the adsorption of hexavalent chromium. Spect. Acta Part A 2013, 116, 17-25. [CrossRef] [PubMed]
92. Kumar, K.M.; Mandal, B.K.; Kumar, K.S.; Reddy, P.S.; Sreedhar, B. Biobased green method to synthesise palladium and iron nanoparticles using Terminalia chebula aqueous extract. Spect. Acta Part A 2013, 102, 128-133. [CrossRef] [PubMed]
93. Wang, Z. Iron complex nanoparticles synthesized by eucalyptus leaves. ACS Sustain. Chem. Eng. 2013, 1, 1551-1554. [CrossRef]
94. Shahwan, T.; Abu Sirriah, S.; Nairat, M.; Boyac, E.; Eroǧlu, A.E.; Scott, T.B.; Hallam, K.R. Green synthesis of iron nanoparticles and their application as a Fenton-like catalyst for the degradation of aqueous cationic and anionic dyes. Chem. Eng. J. 2011, 172, 258-266. [CrossRef]
95. Kuang, Y.; Wang, Q.; Chen, Z.; Megharaj, M.; Naidu, R. Heterogeneous Fenton-like oxidation of monochlorobenzene using green synthesis of iron nanoparticles. J. Colloid Interface Sci. 2013, 410, 67-73. [CrossRef] [PubMed]
96. Senthil, M.; Ramesh, C. Biogenic synthesis of Fe3O4 nanoparticles using Tridax procumbens leaf extract and its antibacterial activity on Pseudomonas aeruginosa. Dig. J. Nanomat. Biostruc. 2012, 7, 1655-1661.
97. Naseem, T.; Farrukh, M.A. Antibacterial activity of green synthesis of iron nanoparticles using Lawsonia inermis and Gardenia jasminoides leaves extract. J. Chem. 2015, 2015, 912342. [CrossRef]
98. Ahamed, M.; Alhadlaq, H.A.; Khan, M.A.; Karuppiah, P.; Al-Dhabi, N.A. Synthesis, characterization, and antimicrobial activity of copper oxide nanoparticles. J. Nanomater. 2014, 1-4. [CrossRef]
99. Pandey, P.; Packiyaraj, M.S.; Nigam, H.; Agarwal, G.S.; Singh, B.; Patra, M.K. Antimicrobial properties of CuO nanorods and multi-armed nanoparticles against B. anthracis vegetative cells and endospores. Beilstein J. Nanotechnol. 2014, 5, 789-800. [CrossRef] [PubMed]
100. Chatterjee, A.K.; Chakraborty, R.; Basu, T. Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology 2014, 25, 135101. [CrossRef] [PubMed]
101. Khashan, K.; Sulaiman, G.; Abdulameer, F. Synthesis and Antibacterial Activity of CuO Nanoparticles Suspension Induced by Laser Ablation in Liquid. Arabian J. Sci. Eng. 2016, 41, 301-310. [CrossRef]
102. Ramyadevi, J.; Jeyasubramanian, K.; Marikani, A.; Rajakumar, G.; Rahuman, A.A. Synthesis and antimicrobial activity of copper nanoparticles. Mater. Lett. 2012, 71, 114-116. [CrossRef]
103. Alswat, A.A.; Ahmad, M.B.; Hussein, M.Z.; Ibrahim, N.A.; Saleh, T.A. Copper oxide nanoparticles-loaded zeolite and its characteristics and antibacterial activities. J. Mater. Sci. Technol. 2017. [CrossRef]
104. Rani, R.; Kumar, H.; Salar, R.K.; Purewal, S.S. Antibacterial activity of copper oxide nanoparticles against gram-negative bacterial strain synthesized by reverse micelle technique. Int. J. Pharm. Res. Dev. 2014, 6, 72-78.
105. Hsueh, Y.H.; Tsai, P.H.; Lin, K.S. pH-Dependent antimicrobial properties of copper oxide nanoparticles in Staphylococcus aureus. Int. J. Mol. Sci. 2017, 18, 793. [CrossRef] [PubMed]
106. Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.; Memic, A. Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and-negative bacterial strains. Int. J. Nanomed. 2012, 7, 3527-3535. [CrossRef] [PubMed]
107. Das, D.; Nath, B.C.; Phukon, P.; Dolui, S.K. Synthesis and evaluation of antioxidant and antibacterial behaviour of CuO nanoparticles. Colloids Surf. B 2013, 101, 430-433. [CrossRef] [PubMed]
108. Jadhav, S.; Gaikwad, S.; Nimse, M.; Rajbhoj, A. Copper oxide nanoparticles: Synthesis, characterization and their antibacterial activity. J. Cluster Sci. 2011, 22, 121-129. [CrossRef]
109. Gilbertson, L.M.; Albalghiti, E.M.; Fishman, Z.S.; Perreault, F.; Corredor, C.; Posner, J.D.; Elimelech, M.; Pfefferle, L.D.; Zimmerman, J.B. Shape-dependent surface reactivity and antimicrobial activity of nano-cupric oxide. Environ. Sci. Technol. 2016, 50, 3975-3984. [CrossRef] [PubMed]
110. Bondarenko, O.; Ivask, A.; Käkinen, A.; Kahru, A. Sub-toxic effects of CuO nanoparticles on bacteria: Kinetics, role of Cu ions and possible mechanisms of action. Environ. Pollut. 2012, 169, 81-89. [CrossRef] [PubMed]
111. Kaweeteerawat, C.; Chang, C.H.; Roy, K.R.; Liu, R.; Li, R.; Toso, D.; Fischer, H.; Ivask, A.; Ji, Z.; Zink, J.I.; et al. Cu nanoparticles have different impacts in Escherichia coli and Lactobacillus brevis than their microsized and ionic analogues. ACS Nano 2015, 9, 7215-7225. [CrossRef] [PubMed]
112. Guo, J.; Gao, S.H.; Lu, J.; Bond, P.L.; Verstraete,W.; Yuan, Z. Copper oxide nanoparticles induce lysogenic bacteriophage and metal resistance genes in Pseudomonas aeruginosa PAO1. ACS Appl. Mater. Interfaces 2017. [CrossRef] [PubMed]
113. Abboud, Y.; Saffaj, T.; Chagraoui, A.; El Bouari, A.; Brouzi, K.; Tanane, O.; Ihssane, B. Biosynthesis, characterization and antimicrobial activity of copper oxide nanoparticles (CONPs) produced using brown alga extract (Bifurcaria bifurcata). Appl. Nanosci. 2014, 4, 571-576. [CrossRef]
114. Meghana, S.; Kabra, P.; Chakraborty, S.; Padmavathy, N. Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv. 2015, 5, 12293-12299. [CrossRef]
115. Reddy, L.S.; Nisha, M.M.; Joice, M.; Shilpa, P.N. Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae. Pharm Biol. 2014, 52, 1388-1397. [CrossRef] [PubMed]
116. Raghupathi, K.R.; Koodali, R.T.; Manna, A.C. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 2011, 27, 4020-4028. [CrossRef] [PubMed]
117. Hsueh, Y.H.; Ke, W.J.; Hsieh, C.T.; Lin, K.S.; Tzou, D.Y.; Chiang, C.L. ZnO nanoparticles affect Bacillus subtilis cell growth and biofilm formation. PLoS ONE 2015, 10, e0128457. [CrossRef] [PubMed]
118. Narasimha, G.; Sridevi, A.; Devi Prasad, B.; Praveen Kumar, B. Chemical synthesis of Zinc Oxide (ZnO) nanoparticles and their antibacterial activity against a clinical isolate Staphylococcus aureus. Int. J. Nano Dimens. 2014, 5, 337-340.
119. Xie, Y.; He, Y.; Irwin, P.L.; Jin, T.; Shi, X. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol. 2011, 77, 2325-2331. [CrossRef] [PubMed]
120. Dobrucka, R.; Dlugaszewska, J. Biosynthesis and antibacterial activity of ZnO nanoparticles using Trifolium pratense flower extract. Saudi J. Biol. Sci. 2016, 23, 517-523. [CrossRef] [PubMed]
121. Dutta, R.K.; Nenavathu, B.P.; Gangishetty, M.K.; Reddy, A.V. Studies on antibacterial activity of ZnO nanoparticles by ROS induced lipid peroxidation. Colloids Surf. B Biointerface. 2012, 94, 143-150. [CrossRef] [PubMed]
122. Krithika, G.; Saraswathy, R.; Muralidhar, M.; Thulasi, D.; Lalitha, N.; Kumararaja, P.; Nagavel, A.; Balaji, A.; Jayavel, R. Zinc oxide nanoparticles-Synthesis, characterization and antibacterial activity. J. Nanosci. Nanotechnol. 2017, 17, 5209-5216. [CrossRef]
123. Hameed, A.S.; Karthikeyan, C.; Ahamed, A.P.; Thajuddin, N.; Alharbi, N.S.; Alharbi, S.A.; Ravi, G. In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae. Sci. Rep. 2016, 6. [CrossRef] [PubMed]
124. Mirhosseini, M.; Firouzabadi, F.B. Antibacterial activity of zinc oxide nanoparticle suspensions on food-borne pathogens. Int. J. Dairy Technol. 2013, 66, 291-295. [CrossRef]
125. Liu, Y.; He, L.; Mustapha, A.; Li, H.; Hu, Z.Q.; Lin, M. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157: H7. J. Appl. Microbiol. 2009, 107, 1193-1201. [CrossRef] [PubMed]
126. Seil, J.T.; Webster, T.J. Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnol 2012, 23, 495101. [CrossRef] [PubMed]
127. Rago, I.; Chandraiahgari, C.R.; Bracciale, M.P.; De Bellis, G.; Zanni, E.; Guidi, M.C.; Sali, D.; Broggi, A.; Palleschi, C.; Sarto, M.S.; et al. Zinc oxide microrods and nanorods: Different antibacterial activity and their mode of action against Gram-positive bacteria. RSC Adv. 2014, 4, 56031-56040. [CrossRef]
128. Voicu, G.; Oprea, O.; Vasile, B.S.; Andronescu, E. Antibacterial activity of zinc oxide-gentamicin hybrid material. Dig. J. Nanomater. Biostruct. 2013, 8, 1191-1203.
129. Stan, M.; Popa, A.; Toloman, D.; Silipas, T.D.; Vodnar, D.C.; Katona, G. Enhanced antibacterial activity of zinc oxide nanoparticles synthesized using Petroselinum crispum extracts. In Proceedings of the AIP Conference, Cluj-Napoca, Romania, 23-25 December 2015.
130. Gunalan, S.; Sivaraj, R.; Rajendran, V. Green synthesized ZnO nanoparticles against bacterial and fungal pathogens. Prog. Nat. Sci. Mater. Int. 2012, 22, 693-700. [CrossRef]
131. Venkataraju, J.L.; Sharath, R.; Chandraprabha, M.N.; Neelufar, E.; Hazra, A.; Patra, M. Synthesis, characterization and evaluation of antimicrobial activity of zinc oxide nanoparticles. J. Biochem. Technol. 2014, 3, 151-154.
132. Sadiq, I.M.; Chowdhury, B.; Chandrasekaran, N.; Mukherjee, A. Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2009, 5, 282-286. [CrossRef] [PubMed]
133. Jalal, M.; Ansari, M.A.; Shukla, A.K.; Ali, S.G.; Khan, H.M.; Pal, R.; Alam, J.; Cameotra, S.S. Green synthesis and antifungal activity of Al2O3 NPs against fluconazole-resistant Candida spp. isolated from a tertiary care hospital. RSC Adv. 2016, 6, 107577-107590. [CrossRef]
134. Ansari, M.A.; Khan, H.M.; Alzohairy, M.A.; Jalal, M.; Ali, S.G.; Pal, R.; Musarrat, J. Green synthesis of Al2O3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa. World J. Microbiol. Biotechnol. 2015, 31, 153-164. [CrossRef] [PubMed]
135. Prashanth, P.A.; Raveendra, R.S.; Krishna, R.H.; Ananda, S.; Bhagya, N.P.; Nagabhushana, B.M.; Lingaraju, K.; Naika, H.R. Synthesis, characterizations, antibacterial and photoluminescence studies of solution combustion-derived α-Al2O3 nanoparticles. J. Asian Ceram. Soc. 2015, 3, 345-351. [CrossRef]
136. Brintha, S.R.; Ajitha, M. Synthesis, structural and antibacterial activity of aluminium and nickel doped ZnO nanoparticles by Sol-gel method. Asian J. Chem. Sci. 2016, 1, 1-9. [CrossRef]
137. Mohamed, M.M.; Fouad, S.A.; Elshoky, H.A.; Mohammed, G.M.; Salaheldin, T.A. Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis. Int. J. Vet. Sci. Med. 2017, 5, 23-29. [CrossRef]
138. Zhou, Y.; Kong, Y.; Kundu, S.; Cirillo, J.D.; Liang, H. Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin. J. Nanobiotechnol. 2012, 10, 19. [CrossRef] [PubMed]
139. Li, X.; Robinson, S.M.; Gupta, A.; Saha, K.; Jiang, Z.; Moyano, D.F.; Sahar, A.; Riley, M.A.; Rotello, V.M. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano 2014, 8, 10682-10686. [CrossRef] [PubMed]
140. Shamaila, S.; Zafar, N.; Riaz, S.; Sharif, R.; Nazir, J.; Naseem, S. Gold nanoparticles: An efficient antimicrobial agent against enteric bacterial human pathogen. Nanomater 2016, 6. [CrossRef] [PubMed]
141. Shareena Dasari, T.P.; Zhang, Y.; Yu, H. Antibacterial activity and cytotoxicity of gold (I) and (III) Ions and gold nanoparticles. Biochem. Pharmacol. 2015, 4. [CrossRef]
142. Lima, E.; Guerra, R.; Lara, V.; Guzmán, A. Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem. Cent. J. 2013, 7. [CrossRef] [PubMed]
143. MubarakAli, D.; Thajuddin, N.; Jeganathan, K.; Gunasekaran, M. Plant extract mediated synthesis of silver and gold nanoparticles and its antibacterial activity against clinically isolated pathogens. Colloids Surf. B 2011, 85, 360-365. [CrossRef] [PubMed]
144. Zhang, Y.; Shareena Dasari, T.P.; Deng, H.; Yu, H. Antimicrobial activity of gold nanoparticles and ionic gold. J. Environ. Sci. Health Part C 2015, 33, 286-327. [CrossRef] [PubMed]
145. Rai, A.; Prabhune, A.; Perry, C.C. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J. Mater. Chem. 2010, 20, 6789-6798. [CrossRef]
146. Cui, Y.; Zhao, Y.; Tian, Y.; Zhang, W.; Lü, X.; Jiang, X. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials 2012, 33, 2327-2333. [CrossRef] [PubMed]
147. Bankar, A.; Joshi, B.; Kumar, A.R.; Zinjarde, S. Banana peel extract mediated synthesis of gold nanoparticles. Colloids Surf. B 2010, 80, 45-50. [CrossRef] [PubMed]
148. Ahmed, K.B.; Subramanian, S.; Sivasubramanian, A.; Veerappan, G.; Veerappan, A. Preparation of gold nanoparticles using Salicornia brachiata plant extract and evaluation of catalytic and antibacterial activity. Spectrochim. Acta Mol. Biomol. Spectrosc. 2014, 130, 54-58. [CrossRef] [PubMed]
149. Rajathi, F.A.; Parthiban, C.; Kumar, V.G.; Anantharaman, P. Biosynthesis of antibacterial gold nanoparticles using brown alga, Stoechospermum marginatum (kützing). Spectrochim. Acta Mol. Biomol. Spectrosc. 2012, 99, 166-173. [CrossRef] [PubMed]
150. Bindhu, M.R.; Umadevi, M. Antibacterial activities of green synthesized gold nanoparticles. Mater. Lett. 2014, 120, 122-125. [CrossRef]
151. Prasad, T.N.; Elumalai, E.K. Biofabrication of Ag nanoparticles using Moringa oleifera leaf extract and their antimicrobial activity. Asian Pac. J. Trop. Biomed. 2011, 1, 439-442. [CrossRef]
152. Arshi, N.; Ahmed, F.; Kumar, S.; Anwar, M.S.; Lu, J.; Koo, B.H.; Lee, C.G. Microwave assisted synthesis of gold nanoparticles and their antibacterial activity against Escherichia coli (E. coli). Curr. Appl. Phys. 2011, 11, S360-S363. [CrossRef]
153. Burygin, G.L.; Khlebtsov, B.N.; Shantrokha, A.N.; Dykman, L.A.; Bogatyrev, V.A.; Khlebtsov, N.G. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res. Lett. 2009, 4, 794. [CrossRef] [PubMed]
154. Zharov, V.P.; Mercer, K.E.; Galitovskaya, E.N.; Smeltzer, M.S. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys. J. 2006, 90, 619-627. [CrossRef] [PubMed]
155. Shokri, R.; Salouti, M.; Zanjani, R.S. Anti protein A antibody-gold nanorods conjugate: A targeting agent for selective killing of methicillin resistant Staphylococcus aureus using photothermal therapy method. J. Microbiol. 2015, 53, 116-121. [CrossRef] [PubMed]
156. Huang, W.C.; Tsai, P.J.; Chen, Y.C. Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. Nanomedicine 2007, 2, 777-787. [CrossRef] [PubMed]
157. Gu, H.; Ho, P.L.; Tong, E.; Wang, L.; Xu, B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 2003, 3, 1261-1263. [CrossRef]
158. Saha, B.; Bhattacharya, J.; Mukherjee, A.; Ghosh, A.; Santra, C.; Dasgupta, A.K.; Karmakar, P. In Vitro structural and functional evaluation of gold nanoparticles conjugated antibiotics. Nanoscale Res. Lett. 2007, 2, 614. [CrossRef]
159. Bagga, P.; Ansari, T.M.; Siddiqui, H.H.; Syed, A.; Bahkali, A.H.; Rahman, M.A.; Khan, M.S. Bromelain capped gold nanoparticles as the novel drug delivery carriers to aggrandize effect of the antibiotic levofloxacin. EXCLI J. 2016, 15, 772-780. [PubMed]
160. Jesline, A.; John, N.P.; Narayanan, P.M.; Vani, C.; Murugan, S. Antimicrobial activity of zinc and titanium dioxide nanoparticles against biofilm-producing methicillin-resistant Staphylococcus aureus. Appl. Nanosci. 2015, 5, 157-162. [CrossRef]
161. 2 nanoparticles against Microbial Isolates causing dental plaques. Int. J. Bioassays. 2014, 3, 3106-3110.
162. Santhoshkumar, T.; Rahuman, A.A.; Jayaseelan, C.; Rajakumar, G.; Marimuthu, S.; Kirthi, A.V.; Velayutham, K.; Thomas, J.; Venkatesan, J.; Kim, S.K. Green synthesis of titanium dioxide nanoparticles using Psidium guajava extract and its antibacterial and antioxidant properties. Asian Pac. J. Trop. Med. 2014, 7, 968-976. [CrossRef]
163. Besinis, A.; De Peralta, T.; Handy, R.D. The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays. Nanotoxicol 2014, 8, 1-6. [CrossRef] [PubMed]
164. Alhadrami, H.A.; Al-Hazmi, F. Antibacterial Activities of Titanium Oxide Nanoparticles. J. Bioelectron. Nanotechnol. 2017, 2, 5.
165. Desai, V.S.; Meenal, K. Antimicrobial activity of titanium dioxide nanoparticles synthesized by sol-gel technique. Res. J. Microbiol. 2009, 4, 97-103.
166. 2 nanoparticles to Escherichia coli: Effects of particle size, crystal phase and water chemistry. PLoS ONE 2014, 9, e110247. [CrossRef] [PubMed]
167. 2 nanoparticles in natural and artificial waters. Colloids Surf. B. 2013, 102, 158-164. [CrossRef] [PubMed]
168. 2 to Escherichia coli assessed by high-throughput screening: Effects of environmental factors. Water Res. 2013, 47, 2352-2362. [CrossRef] [PubMed]
169. Narayanasamy, P.; Switzer, B.L.; Britigan, B.E. Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages. Sci. Rep. 2015, 5. [CrossRef] [PubMed]
170. Kurtjak, M.; Vukomanović, M.; Kramer, L.; Suvorov, D. Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity. J. Mater. Sci. Mater. Med. 2016, 27, 170. [CrossRef] [PubMed]
171. Choi, S.R.; Britigan, B.E.; Moran, D.M.; Narayanasamy, P. Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages. PLoS ONE 2017, 12, e0177987. [CrossRef] [PubMed]
172. Olakanmi, O.; Gunn, J.S.; Su, S.; Soni, S.; Hassett, D.J.; Britigan, B.E. Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob. Agents Chemother. 2010, 54, 244-253. [CrossRef] [PubMed]
173. Strasfeld, L.; Chou, S. Antiviral drug resistance: Mechanisms and clinical implications. Infect. Dis. Clin. N. Am. 2010, 24, 809-833. [CrossRef] [PubMed]
174. Global AIDS/HIV Epidermic. Available online: https://www.aids.gov/hiv-aids-basics/hiv-aids-101/global-statistics/(accessed on 21 April 2017).
175. Lara, H.H.; Ayala-Nuñez, N.V.; Ixtepan-Turrent, L.; Rodriguez-Padilla, C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 2010, 8. [CrossRef] [PubMed]
176. Sun, R.W.; Rong, C.; Chung, N.P.Y.; Ho, C.M.; Lin, C.L.S.; Che, C.M. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem. Commun. 2005, 40, 5059-5061. [CrossRef] [PubMed]
177. Elechiguerra, J.L.; Burt, J.L.; Morones, J.R.; Camacho-Bragado, A.; Gao, X.; Lara, H.H.; Yacaman, M.J. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 2005, 3, 6. [CrossRef] [PubMed]
178. Choi, S.R.; Britigan, B.E.; Narayanasamy, P. Ga (III) nanoparticles inhibit growth of both Mycobacterium tuberculosis and HIV and release of interleukin-6 (IL-6) and IL-8 in coinfected macrophages. Antimicrob. Agents Chemother. 2017, 61, e02505-16. [CrossRef] [PubMed]
179. Endsley, A.N.; Ho, R.J.Y. Enhanced anti-HIV efficacy of indinavir after Inclusion in CD4 targeted lipid nanoparticles. J. Acquir. Immune Defic. Syndr. 2012, 61, 417-424. [CrossRef] [PubMed]
180. Soto, E.R.; O'Connell, O.; Dikengil, F.; Peters, P.J.; Clapham, P.R.; Ostroff, G.R. Targeted delivery of glucan particle encapsulated gallium nanoparticles inhibits HIV growth in human macrophages. J. Drug Deliv. 2016. [CrossRef] [PubMed]
181. Kesarkar, R.; Shroff, S.; Yeole, M.; Chowdhary, A. L-Cysteine Functionalized Gold Nanocargos Potentiates Anti-HIV Activity of Azidothymydine against HIV-1Ba-L Virus. J. Immunol. Virol. 2015, 1. [CrossRef]
182. Vijayakumar, S.; Ganesan, S. Gold nanoparticles as an HIV entry inhibitor. Curr. HIV Res. 2012, 10, 643-646. [CrossRef] [PubMed]
183. Garrido, C.; Simpson, C.A.; Dahl, N.P.; Bresee, J.; Whitehead, D.C.; Lindsey, E.A.; Harris, T.L.; Smith, C.A.; Carter, C.J.; Feldheim, D.L.; et al. Gold nanoparticles to improve HIV drug delivery. Futur. Med. Chem. 2015, 7, 1097-1107. [CrossRef] [PubMed]
184. Kesarkar, R.; Oza, G.; Pandey, S.; Dahake, R.; Mukherjee, S.; Chowdhary, A.; Sharon, M. Gold nanoparticles: Effective as both entry inhibitors and virus neutralizing agents against HIV. J. Microbiol. Biotechnol. Res. 2017, 2, 276-283.
185. Chiodo, F.; Marradi, M.; Calvo, J.; Yuste, E.; Penadés, S. Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J. Org. Chem. 2014, 10, 1339-1346. [CrossRef] [PubMed]
186. Bowman, M.C.; Ballard, T.E.; Ackerson, C.J.; Feldheim, D.L.; Margolis, D.M.; Melander, C. Inhibition of HIV fusion with multivalent gold nanoparticles. J. Am. Chem. Soc. 2008, 130, 6896-6897. [CrossRef] [PubMed]
187. Bastian, A.R.; Nangarlia, A.; Bailey, L.D.; Holmes, A.; Sundaram, R.V.; Ang, C.; Moreira, D.R.; Freedman, K.; Duffy, C.; Contarino, M.; et al. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation. J. Biol. Chem. 2015, 290, 529-543. [CrossRef] [PubMed]
188. Shen, Y.; Nemunaitis, J. Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Ther. 2006, 13, 975-992. [CrossRef] [PubMed]
189. Vonka, V.; Kanaka, J.; Hirsch, I.; Zavadova, H.; Krčmář, M.; Suchankova, A.; Řezácová, D.; Brouček, J.; Press, M.; Domorazkova, E.; et al. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrolment. Int. J. Cancer 1984, 33, 61-66. [CrossRef] [PubMed]
190. Trigilio, J.; Antoine, T.E.; Paulowicz, I.; Mishra, Y.K.; Adelung, R.; Shukla, D. Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion. PLoS ONE 2012, 7, e48147. [CrossRef] [PubMed]
191. Hu, R.L.; Li, S.R.; Kong, F.J.; Hou, R.J.; Guan, X.L.; Guo, F. Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet. Mol. Res. 2014, 13, 7022-7028. [CrossRef] [PubMed]
192. Orlowski, P.; Tomaszewska, E.; Gniadek, M.; Baska, P.; Nowakowska, J.; Sokolowska, J.; Nowak, Z.; Donten, M.; Celichowski, G.; Grobelny, J.; et al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS ONE 2014, 9, e104113. [CrossRef] [PubMed]
193. Baram-Pinto, D.; Shukla, S.; Perkas, N.; Gedanken, A.; Sarid, R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconj. Chem. 2009, 20, 1497-1502. [CrossRef] [PubMed]
194. Fayaz, A.M.; Ao, Z.; Girilal, M.; Chen, L.; Xiao, X.; Kalaichelvan, P.T.; Yao, X. Inactivation of microbial infectiousness by silver nanoparticles-coated condom: A new approach to inhibit HIV-and HSV-transmitted infection. Int. J. Nanomed. 2012, 7, 5007-5018.
195. Gaikwad, S.; Ingle, A.; Gade, A.; Rai, M.; Falanga, A.; Incoronato, N.; Russo, L.; Galdiero, S.; Galdiero, M. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J. Nanomed. 2013, 8, 4303-4314.
196. Antoine, T.E.; Hadigal, S.R.; Yakoub, A.M.; Mishra, Y.K.; Bhattacharya, P.; Haddad, C.; Valyi-Nagy, T.; Adelung, R.; Prabhakar, B.S.; Shukla, D. Intravaginal zinc oxide tetrapod nanoparticles as novel immunoprotective agents against genital herpes. J. Immunol. 2016, 196, 4566-4575. [CrossRef] [PubMed]
197. Mishra, Y.K.; Adelung, R.; Röhl, C.; Shukla, D.; Spors, F.; Tiwari, V. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. Antivir. Res. 2011, 92, 305-312. [CrossRef] [PubMed]
198. Sarid, R.; Gedanken, A.; Baram-Pinto, D. Pharmaceutical Compositions Comprising Water-Soluble Sulfonate-Protected Nanoparticles and Uses Thereof. U.S. Patent 20120027809 A1, 2 February 2012.
199. Baram-Pinto, D.; Shukla, S.; Gedanken, A.; Sarid, R. Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles. Small 2010, 6, 1044-1050. [CrossRef] [PubMed]
200. Samji, N.S.; Anand, B.S. Viral Hepatitis. 2017. Available online: http://emedicine.medscape.com/article/775507-overview#a7 (accessed on 12 July 2017).
201. Lu, L.; Sun, R.W.; Chen, R.; Hui, C.K.; Ho, C.M.; Luk, J.M.; Lau, G.K.; Che, C.M. Silver nanoparticles inhibit hepatitis B virus replication. Antivir. Ther. 2008, 13, 253-262. [PubMed]
202. Ryoo, S.R.; Jang, H.; Kim, K.S.; Lee, B.; Kim, K.B.; Kim, Y.K.; Yeo, W.S.; Lee, Y.; Kim, D.E.; Min, D.H. Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. Biomaterials 2012, 33, 2754-2761. [CrossRef] [PubMed]
203. Hang, X.; Peng, H.; Song, H.; Qi, Z.; Miao, X.; Xu,W. Antiviral activity of cuprous oxide nanoparticles against hepatitis C virus in vitro. J. Virol. Methods. 2015, 222, 150-157. [CrossRef] [PubMed]
204. Yasri, S.; Wiwanitkit, V. Effect of gold nanoparticle on viral load of hepatitis C virus. J. Coast. Life Med. 2014, 2, 2754-2761.
205. Lee, M.Y.; Yang, J.A.; Jung, H.S.; Beack, S.; Choi, J.E.; Hur, W.; Koo, H.; Kim, K.; Yoon, S.K.; Hahn, S.K. Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection. ACS Nano 2012, 6, 9522-9531. [CrossRef] [PubMed]
206. Taubenberger, J.K.; Morens, D.M. The pathology of influenza virus infections. Annu. Rev. Pathmechdis. Mech. Dis. 2008, 3, 499-522. [CrossRef] [PubMed]
207. Feng, F.; Sakoda, Y.; Ohyanagi, T.; Nagahori, N.; Shibuya, H.; Okamastu, M.; Miura, N.; Kida, H.; Nishimura, S.I. Novel thiosialosides tethered to metal nanoparticles as potent influenza A virus haemagglutinin blockers. Antivir. Chem. Chemother. 2013, 23, 59-65. [CrossRef] [PubMed]
208. Xiang, D.; Yang, Z.; Duan,W.; Li, X.; Yin, J.; Shigdar, S.; O'Connor, M.L.; Marappan, M.; Zhao, X.; Miao, Y.; et al. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int. J. Nanomed. 2013, 8, 4103-4114. [CrossRef] [PubMed]
209. Mori, Y.; Ono, T.; Miyahira, Y.; Nguyen, V.Q.; Matsui, T.; Ishihara, M. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res. Lett. 2013, 8, 1-6. [CrossRef] [PubMed]
210. Li, Y.; Lin, Z.; Zhao, M.; Guo, M.; Xu, T.;Wang, C.; Xia, H.; Zhu, B. Reversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadine. RSC Adv. 2016, 6, 89679-89686. [CrossRef]
211. Sametband, M.; Shukla, S.; Meningher, T.; Hirsh, S.; Mendelson, E.; Sarid, R.; Gedanken, A.; Mandelboim, M. Effective multi-strain inhibition of influenza virus by anionic gold nanoparticles. Med. Chem. Commun. 2011, 2, 421-423. [CrossRef]
212. Xiang, D.X.; Chen, Q.; Pang, L.; Zheng, C.L. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J. Virol. Methods 2011, 178, 137-142. [CrossRef] [PubMed]
213. Mehrbod, P.; Motamed, N.; Tabatabaian, M.; Estyar, R.S.; Amini, E.; Shahidi, M.; Kheiri, M.T. In vitro antiviral effect of "Nanosilver" on influenza virus. DARU J. Pharm. Sci. 2015, 17, 88-93.
214. Pink, R.; Hudson, A.; Mouriès, M.A.; Bendig, M. Opportunities and challenges in antiparasitic drug discovery. Nat. Rev. Drug Discov. 2005, 4, 727-740. [CrossRef] [PubMed]
215. Bushman, M.; Morton, L.; Duah, N.; Quashie, N.; Abuaku, B.; Koram, K.A.; Dimbu, P.R.; Plucinski, M.; Gutman, J.; Lyaruu, P.; et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proc. R. Soc. B 2016, 283, 20153038. [CrossRef] [PubMed]
216. Mishra, A.; Kaushik, N.K.; Sardar, M.; Sahal, D. Evaluation of antiplasmodial activity of green synthesized silver nanoparticles. Colloids Surf. B 2013, 111, 713-718. [CrossRef] [PubMed]
217. Jaganathan, A.; Murugan, K.; Panneerselvam, C.; Madhiyazhagan, P.; Dinesh, D.; Vadivalagan, C.; Chandramohan, B.; Suresh, U.; Rajaganesh, R.; Subramaniam, J.; et al. Earthworm-mediated synthesis of silver nanoparticles: A potent tool against hepatocellular carcinoma, Plasmodium falciparum parasites and malaria mosquitoes. Parasitol. Int. 2016, 65, 276-284. [CrossRef] [PubMed]
218. Murugan, K.; Panneerselvam, C.; Subramaniam, J.; Madhiyazhagan, P.; Hwang, J.S.; Wang, L.; Dinesh, D.; Suresh, U.; Roni, M.; Higuchi, A.; et al. Eco-friendly drugs from the marine environment: Spongeweed-synthesized silver nanoparticles are highly effective on Plasmodium falciparum and its vector Anopheles stephensi, with little non-target effects on predatory copepods. Environ. Sci. Pollut. Res. 2016, 23, 16671-16685. [CrossRef] [PubMed]
219. Murugan, K.; Panneerselvam, C.; Samidoss, C.M.; Madhiyazhagan, P.; Suresh, U.; Roni, M.; Chandramohan, B.; Subramaniam, J.; Dinesh, D.; Rajaganesh, R.; et al. In vivo and in vitro effectiveness of Azadirachta indica-synthesized silver nanocrystals against Plasmodium berghei and Plasmodium falciparum, and their potential against malaria mosquitoes. Res. Vet. Sci. 2016, 106, 14-22. [CrossRef] [PubMed]
220. Inbaneson, S.J.; Ravikumar, S. In vitro antiplasmodial activity of PDDS-coated metal oxide nanoparticles against Plasmodium falciparum. Appl. Nanosci. 2013, 3, 197-201. [CrossRef]
221. Karthik, L.; Kumar, G.; Keswani, T.; Bhattacharyya, A.; Reddy, B.P.; Rao, K.B. Marine actinobacterial mediated gold nanoparticles synthesis and their antimalarial activity. Nanomed. Nanotechnol. Biol. Med. 2013, 9, 951-960. [CrossRef] [PubMed]
222. Dutta, P.P.; Bordoloi, M.; Gogoi, K.; Roy, S.; Narzary, B.; Bhattacharyya, D.R.; Mohapatra, P.K.; Mazumder, B. Antimalarial silver and gold nanoparticles: Green synthesis, characterization and in vitro study. Biomed. Pharmacother. 2017, 91, 567-580. [CrossRef] [PubMed]
223. Starke, C.G. Leishmaniasis. 2017. Available online: http://emedicine.medscape.com/article/220298-overview (accessed on 12 July 2017).
224. Mohapatra, S. Drug resistance in leishmaniasis: Newer developments. Trop. Parasitol. 2014, 4, 4-9. [CrossRef] [PubMed]
225. Ameneh, S.; Khadije, M.; Ahmad-Reza, T.; Omid, R. Inhibition of Leishmania major growth by Ultraviolet radiation B with Silver nanoparticles in an animal model. In Proceedings of theWorld Congress on Advances in Nano, Biomechanics, Robotics and Energy Research, Seoul, Korea, 25-28 August 2013.
226. Rossi-Bergmann, B.; Pacienza-Lima, W.; Marcato, P.D.; De Conti, R.; Duran, N. Therapeutic potential of biogenic silver nanoparticles in murine cutaneous leishmaniasis. J. Nano Res. 2012, 20, 89-97. [CrossRef]
227. Lima, D.D.; Gullon, B.; Cardelle-Cobas, A.; Brito, L.M.; Rodrigues, K.A.; Quelemes, P.V.; Ramos-Jesus, J.; Arcanjo, D.D.; Plácido, A.; Batziou, K.; et al. Chitosan-based silver nanoparticles: A study of the antibacterial, antileishmanial and cytotoxic effects. J. Bioact. Compat. Polym. 2016, 32, 397-410. [CrossRef]
228. Ahmad, A.; Syed, F.; Shah, A.; Khan, Z.; Tahir, K.; Khan, A.U.; Yuan, Q. Silver and gold nanoparticles from Sargentodoxa cuneata: Synthesis, characterization and antileishmanial activity. RSC Adv. 2015, 5, 73793-73806. [CrossRef]
229. Zahir, A.A.; Chauhan, I.S.; Bagavan, A.; Kamaraj, C.; Elango, G.; Shankar, J.; Arjaria, N.; Roopan, S.M.; Rahuman, A.A.; Singh, N. Green synthesis of silver and titanium dioxide nanoparticles using Euphorbia prostrata extract shows shift from apoptosis to G0/G1 arrest followed by necrotic cell death in Leishmania donovani. Antimicrob. Agents Chemother. 2015, 59, 4782-4799. [CrossRef] [PubMed]
230. Halder, A.; Das, S.; Bera, T.; Mukherjee, A. Rapid synthesis for monodispersed gold nanoparticles in kaempferol and anti-leishmanial efficacy against wild and drug resistant strains. RSC Adv. 2017, 7, 14159-14167. [CrossRef]
231. Torabi, N.; Mohebali, M.; Shahverdi, A.R.; Rezayat, S.M.; Edrissian, G.H.; Esmaeili, J.; Charehdar, S. Nanogold for the treatment of zoonotic cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): An animal trial with methanol extract of Eucalyptus camaldulensis. J. Pharm. Sci. 2012, 1, 113-116.
232. Jebali, A.; Kazemi, B. Nano-based antileishmanial agents: A toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis. Toxicol. In Vitro 2013, 27, 1896-1904. [CrossRef] [PubMed]
233. Delavari, M.; Dalimi, A.; Ghaffarifar, F.; Sadraei, J. In vitro study on cytotoxic effects of ZnO nanoparticles on promastigote and amastigote forms of Leishmania major (MRHO/IR/75/ER). Iran. J. Parasitol. 2014, 9, 6-13. [PubMed]
234. Nadhman, A.; Khan, M.I.; Nazir, S.; Khan, M.; Shahnaz, G.; Raza, A.; Shams, D.F.; Yasinzai, M. Annihilation of Leishmania by daylight responsive ZnO nanoparticles: A temporal relationship of reactive oxygen species-induced lipid and protein oxidation. Int. J. Nanomed. 2016, 11, 2451-2461. [CrossRef] [PubMed]
235. Hotez, P.J.; Brindley, P.J.; Bethony, J.M.; King, C.H.; Pearce, E.J.; Jacobson, J. Helminth infections: The great neglected tropical diseases. J. Clin. Investig. 2008, 118, 1311-1312. [CrossRef] [PubMed]
236. Hedley, L.; Wani, R.L.S. Helminth Infections: Diagnosis and Treatment. 2015. Available online: http://www.pharmaceutical-journal.com/learning/learning-article/helminth-infections-diagnosis-andtreatment/20069529.article (accessed on 13 July 2017).
237. Rashid, M.M.; Ferdous, J.; Banik, S.; Islam, M.R.; Uddin, A.M.; Robel, F.N. Anthelmintic activity of silver-extract nanoparticles synthesized from the combination of silver nanoparticles and M. Charantia. fruit extract. BMC Complement. Altern. Med. 2016, 16, 242. [CrossRef] [PubMed]
238. Kar, P.K.; Murmu, S.; Saha, S.; Tandon, V.; Acharya, K. Anthelmintic efficacy of gold nanoparticles derived from a phytopathogenic fungus, Nigrospora oryzae. PLoS ONE 2014, 9, e84693. [CrossRef] [PubMed]
239. Khan, Y.A.; Singh, B.R.; Ullah, R.; Shoeb, M.; Naqvi, A.H.; Abidi, S.M. Anthelmintic effect of biocompatible zinc oxide nanoparticles (ZnO NPs) on Gigantocotyle explanatum, a neglected parasite of Indian water buffalo. PLoS ONE 2015, 10, e0133086. [CrossRef] [PubMed]
240. Dorostkar, R.; Ghalavand, M.; Nazarizadeh, A.; Tat, M.; Hashemzadeh, M.S. Anthelmintic effects of zinc oxide and iron oxide nanoparticles against Toxocara vitulorum. Int. Nano Lett. 2017, 7, 157-164. [CrossRef]